Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3346/jkms.2020.35.e231 http://scihub22266oqcxt.onion/10.3346/jkms.2020.35.e231 32567262!7308141!32567262     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Korean+Med+Sci 2020 ; 35 (24): e231 Nephropedia Template TP {{tp|p=32567262|t=2020. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance |pdf=|usr=}}{{32567262}} gab.com Text A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance JO: J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=32567262 #FOAvip There have been controversies on the prophylactic effect of hydroxychloroquine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We describe a patient, 60-year old Korean woman, with coronavirus disease 2019 (COVID-19) who had been taking hydroxychloroquine for 6 months. Her serum and saliva concentrations of hydroxychloroquine were 280 mug/L and 4,890 mug/L, respectively. The present case raises concerns on hydroxychloroquine's role as a prophylactic agent for COVID-19. Twit Text FOAVip A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance ????J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=32567262 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32567262 #FOAvip English Wikipedia <ref>{{Cite pmid|32567262}}</ref> A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance #MMPMID32567262 Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD J Korean Med Sci 2020[Jun]; 35 (24): e231 PMID32567262show ga There have been controversies on the prophylactic effect of hydroxychloroquine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We describe a patient, 60-year old Korean woman, with coronavirus disease 2019 (COVID-19) who had been taking hydroxychloroquine for 6 months. Her serum and saliva concentrations of hydroxychloroquine were 280 mug/L and 4,890 mug/L, respectively. The present case raises concerns on hydroxychloroquine's role as a prophylactic agent for COVID-19. |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Azithromycin/therapeutic use[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |Coronavirus Infections/*drug therapy/*prevention & control[MESH] |Female[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Middle Aged[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*drug therapy/*prevention & control[MESH] |Primary Prevention/methods[MESH]A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance (epmc).pdf DeepDyve Pubget Overpricing